$GKOS
GLAUKOS Corp

2020 Q2 Form 10-Q Financial Statement

#000155837020009980 Filed on August 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2
Revenue $31.56M $58.60M
YoY Change -46.15% 35.77%
Cost Of Revenue $21.67M $7.870M
YoY Change 175.32% 27.76%
Gross Profit $9.890M $50.73M
YoY Change -80.5% 37.1%
Gross Profit Margin 31.34% 86.57%
Selling, General & Admin $38.12M $37.66M
YoY Change 1.22% 31.49%
% of Gross Profit 385.4% 74.23%
Research & Development $18.97M $17.07M
YoY Change 11.14% 35.35%
% of Gross Profit 191.82% 33.65%
Depreciation & Amortization $7.330M $890.0K
YoY Change 723.6% -47.34%
% of Gross Profit 74.12% 1.75%
Operating Expenses $57.09M $56.97M
YoY Change 0.21% 38.11%
Operating Profit -$47.20M -$6.240M
YoY Change 656.36% 46.89%
Interest Expense -$1.280M $90.00K
YoY Change -1522.22% -82.35%
% of Operating Profit
Other Income/Expense, Net -$81.00K $3.000K
YoY Change -2800.0% -100.26%
Pretax Income -$47.28M -$6.237M
YoY Change 658.02% 15.78%
Income Tax -$7.384M $72.00K
% Of Pretax Income
Net Earnings -$39.89M -$6.309M
YoY Change 532.33% 16.88%
Net Earnings / Revenue -126.41% -10.77%
Basic Earnings Per Share -$0.90 -$0.17
Diluted Earnings Per Share -$0.90 -$0.17
COMMON SHARES
Basic Shares Outstanding 44.23M 36.47M
Diluted Shares Outstanding 36.47M

Balance Sheet

Concept 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $394.9M $150.4M
YoY Change 162.57% 25.23%
Cash & Equivalents $267.0M $39.99M
Short-Term Investments $128.0M $110.4M
Other Short-Term Assets $10.50M $14.70M
YoY Change -28.57% 241.86%
Inventory $21.09M $14.04M
Prepaid Expenses
Receivables $26.73M $22.04M
Other Receivables $0.00 $0.00
Total Short-Term Assets $453.2M $201.2M
YoY Change 125.26% 29.47%
LONG-TERM ASSETS
Property, Plant & Equipment $23.21M $20.50M
YoY Change 13.24% 69.4%
Goodwill $66.13M
YoY Change
Intangibles $370.1M
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.90M $13.90M
YoY Change 14.39% 504.35%
Total Long-Term Assets $542.5M $100.9M
YoY Change 437.76% 542.57%
TOTAL ASSETS
Total Short-Term Assets $453.2M $201.2M
Total Long-Term Assets $542.5M $100.9M
Total Assets $995.7M $302.1M
YoY Change 229.62% 76.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.233M $5.052M
YoY Change 82.76% 40.33%
Accrued Expenses $45.60M $25.95M
YoY Change 75.72% 55.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $54.83M $31.00M
YoY Change 76.87% 51.97%
LONG-TERM LIABILITIES
Long-Term Debt $244.4M $68.20M
YoY Change 258.36%
Other Long-Term Liabilities $5.489M $3.413M
YoY Change 60.83% 55.14%
Total Long-Term Liabilities $5.489M $3.413M
YoY Change 60.83% 55.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $54.83M $31.00M
Total Long-Term Liabilities $5.489M $3.413M
Total Liabilities $333.3M $114.3M
YoY Change 191.66% 405.66%
SHAREHOLDERS EQUITY
Retained Earnings -$283.7M -$212.8M
YoY Change 33.31%
Common Stock $943.8M $399.5M
YoY Change 136.24%
Preferred Stock
YoY Change
Treasury Stock (at cost) $132.0K $132.0K
YoY Change 0.0%
Treasury Stock Shares $28.00K $28.00K
Shareholders Equity $662.4M $187.8M
YoY Change
Total Liabilities & Shareholders Equity $995.7M $302.1M
YoY Change 229.62% 76.55%

Cashflow Statement

Concept 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$39.89M -$6.309M
YoY Change 532.33% 16.88%
Depreciation, Depletion And Amortization $7.330M $890.0K
YoY Change 723.6% -47.34%
Cash From Operating Activities -$10.92M $6.600M
YoY Change -265.45% 72.77%
INVESTING ACTIVITIES
Capital Expenditures -$2.730M -$1.870M
YoY Change 45.99% 146.05%
Acquisitions
YoY Change
Other Investing Activities -$17.94M $1.270M
YoY Change -1512.6% -61.52%
Cash From Investing Activities -$20.67M -$600.0K
YoY Change 3345.0% -123.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 243.8M 320.0K
YoY Change 76100.0% -88.73%
NET CHANGE
Cash From Operating Activities -10.92M 6.600M
Cash From Investing Activities -20.67M -600.0K
Cash From Financing Activities 243.8M 320.0K
Net Change In Cash 212.3M 6.320M
YoY Change 3258.39% -31.23%
FREE CASH FLOW
Cash From Operating Activities -$10.92M $6.600M
Capital Expenditures -$2.730M -$1.870M
Free Cash Flow -$8.190M $8.470M
YoY Change -196.69% 84.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Registrant Name
EntityRegistrantName
GLAUKOS Corp
dei Entity Central Index Key
EntityCentralIndexKey
0001192448
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37463
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0945406
dei Entity Address Address Line1
EntityAddressAddressLine1
229 Avenida Fabricante
dei Entity Address City Or Town
EntityAddressCityOrTown
San Clemente
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92672
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
367-9600
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
GKOS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44674910
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266974000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62430000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
127966000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
111553000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26730000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
38417000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
262878000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9326000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
9326000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23210000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22056000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14328000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
15704000
CY2020Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
52833000
CY2020Q2 us-gaap Inventory Net
InventoryNet
21088000
CY2019Q4 us-gaap Inventory Net
InventoryNet
42578000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10464000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7900000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
453222000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
54048000
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
370149000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
382605000
CY2020Q2 us-gaap Goodwill
Goodwill
66134000
CY2019Q4 us-gaap Goodwill
Goodwill
66134000
CY2020Q2 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
6531000
CY2019Q4 gkos Deposit Assets And Other Assets Noncurrent
DepositAssetsAndOtherAssetsNoncurrent
5649000
CY2020Q2 us-gaap Assets
Assets
995733000
CY2019Q4 us-gaap Assets
Assets
818400000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9233000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5781000
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45598000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
51919000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
54831000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
57700000
CY2020Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
183999000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13305000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14195000
CY2020Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
60435000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
58435000
CY2020Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15250000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9632000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5489000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5166000
CY2020Q2 us-gaap Liabilities
Liabilities
333309000
CY2019Q4 us-gaap Liabilities
Liabilities
145128000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44578000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43530000
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44550000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43502000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
45000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
44000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
943706000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
861740000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2467000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1330000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-283662000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189710000
CY2020Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
28000
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
132000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
662424000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
673272000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
995733000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
818400000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31558000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58600000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86894000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
112626000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21668000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7870000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
54197000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14981000
CY2020Q2 us-gaap Gross Profit
GrossProfit
9890000
CY2019Q2 us-gaap Gross Profit
GrossProfit
50730000
us-gaap Gross Profit
GrossProfit
32697000
us-gaap Gross Profit
GrossProfit
97645000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38116000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37656000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88662000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
72581000
CY2020Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
18971000
CY2019Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
17069000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
43844000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
30999000
CY2019Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2245000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2245000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
57087000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
56970000
us-gaap Operating Expenses
OperatingExpenses
132506000
us-gaap Operating Expenses
OperatingExpenses
105825000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-47197000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6240000
us-gaap Operating Income Loss
OperatingIncomeLoss
-99809000
us-gaap Operating Income Loss
OperatingIncomeLoss
-8180000
CY2020Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
590000
CY2019Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
800000
us-gaap Interest And Other Income
InterestAndOtherIncome
1286000
us-gaap Interest And Other Income
InterestAndOtherIncome
1588000
CY2020Q2 gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-1872000
CY2019Q2 gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-1013000
gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-2753000
gkos Interest And Other Expense Income
InterestAndOtherExpenseIncome
-1013000
CY2020Q2 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
1201000
CY2019Q2 gkos Interest And Other Income Net
InterestAndOtherIncomeNet
216000
gkos Interest And Other Income Net
InterestAndOtherIncomeNet
-510000
gkos Interest And Other Income Net
InterestAndOtherIncomeNet
148000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-81000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1977000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
723000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47278000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6237000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101786000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7457000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7384000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
72000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7834000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-39894000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-6309000
us-gaap Net Income Loss
NetIncomeLoss
-93952000
us-gaap Net Income Loss
NetIncomeLoss
-7651000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.90
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.13
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44335000
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36470000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44078000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36338000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-39894000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-6309000
us-gaap Net Income Loss
NetIncomeLoss
-93952000
us-gaap Net Income Loss
NetIncomeLoss
-7651000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-605000
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-230000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
564000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-166000
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1053000
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
289000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
573000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
661000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
448000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
59000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1137000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
495000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39446000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6250000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-92815000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7156000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
673272000
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
4220000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17176000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
689000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-54058000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
641299000
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1634000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13062000
CY2020Q2 gkos Convertible Debt Transaction Costs Amount
ConvertibleDebtTransactionCostsAmount
3267000
CY2020Q2 gkos Convertible Debt Taxes Amount
ConvertibleDebtTaxesAmount
12891000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
81554000
CY2020Q2 gkos Adjustments To Additional Paid In Capital Capped Call Transactions
AdjustmentsToAdditionalPaidInCapitalCappedCallTransactions
-35679000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
448000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-39894000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
662424000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
173860000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
5406000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7129000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
436000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-1342000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
185489000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
319000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8247000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
59000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-6309000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
187805000
us-gaap Profit Loss
ProfitLoss
-93952000
us-gaap Profit Loss
ProfitLoss
-7651000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14644000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1728000
gkos Amortization Operating Lease Right Of Use Asset
AmortizationOperatingLeaseRightOfUseAsset
2577000
gkos Amortization Operating Lease Right Of Use Asset
AmortizationOperatingLeaseRightOfUseAsset
1396000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
557000
gkos Change In Deferred Income Tax Expense Benefit
ChangeInDeferredIncomeTaxExpenseBenefit
-8254000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-15000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-7000
us-gaap Share Based Compensation
ShareBasedCompensation
28073000
us-gaap Share Based Compensation
ShareBasedCompensation
15376000
gkos Stock Option Plan Expenses
StockOptionPlanExpenses
-3172000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
204000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
33000
gkos Amortization Of Discount On Short Term Investments
AmortizationOfDiscountOnShortTermInvestments
-221000
gkos Deferred Rent And Other Liabilities Adjustment
DeferredRentAndOtherLiabilitiesAdjustment
2324000
gkos Deferred Rent And Other Liabilities Adjustment
DeferredRentAndOtherLiabilitiesAdjustment
2090000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11556000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3353000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-21396000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
752000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-1606000
gkos Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
462000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1998000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2011000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
211000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
57000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24022000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6810000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
60883000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
39896000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
45011000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
41069000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3509000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2523000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20039000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2312000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
287500000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
-9614000
gkos Payment For Capped Call Transactions
PaymentForCappedCallTransactions
35679000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6590000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9171000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1278000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
902000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2013000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4348000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
248062000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5725000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
543000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
21000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
204544000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10244000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71756000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38596000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
276300000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48840000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
294000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
91000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates and assumptions. Management considers many factors in selecting appropriate financial accounting policies and controls and in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the accompanying condensed consolidated financial statements relate to revenue recognition, the fair value of the liability component of the Convertible Notes, the incremental borrowing rate related to the Company’s leased assets, stock-based compensation expense and the valuation of certain intangible assets related to the Company’s acquisition of Avedro. Although these estimates are based on the Company’s knowledge of current events and actions it may undertake in the future, this process may result in actual results differing materially from those estimated amounts used in the preparation of the condensed consolidated financial statements. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="color:#212529;">In </span>March 2020, the World Health Organization declared the outbreak caused by the novel strain of coronavirus (COVID-19) to be a global pandemic. While COVID-19 continues to evolve daily and its ultimate outcome is uncertain, it has caused significant disruption to individuals, governments, businesses, and financial markets. The Company’s condensed consolidated financial statements as of and for the three and six months ended June 30, 2020 reflect the Company’s estimates of the impact of the COVID-19 outbreak. The full extent to which the COVID-19 pandemic will directly or indirectly impact the Company’s business, results of operations and financial condition, including sales, expenses, reserves and allowances, manufacturing, clinical trials, research and development costs and employee-related amounts, will depend on future developments that are highly uncertain, including the duration and severity of the COVID-19 outbreak and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets. As a result, there may be changes to the Company’s estimates regarding the impact of COVID-19 in future periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="visibility:hidden;">​</span></p>
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266974000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62430000
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
9326000
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
9326000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
276300000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71756000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1800000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1200000
us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
0
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3957000
us-gaap Inventory Write Down
InventoryWriteDown
7400000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
32108000
CY2020Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
3471000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3884000
CY2020Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
9289000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6586000
CY2020Q2 us-gaap Inventory Gross
InventoryGross
21088000
CY2019Q4 us-gaap Inventory Gross
InventoryGross
42578000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5852000
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4150000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5078000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4029000
CY2020Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
127001000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
980000
CY2020Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
15000
CY2020Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
127966000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
111161000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
409000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
17000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
111553000
CY2020Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
28501000
CY2019Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
39657000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1771000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1240000
CY2020Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
26730000
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
38417000
CY2020Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
8328000
CY2020Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
7320000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
13525000
CY2020Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3369000
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
2784000
CY2020Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5547000
CY2020Q2 gkos Accrued Employee Stock Purchase Plan Current Liabilities
AccruedEmployeeStockPurchasePlanCurrentLiabilities
3084000
CY2020Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
7765000
CY2019Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1133000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18513000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
30520000
CY2020Q2 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
45598000
CY2019Q4 gkos Accrued Liabilities And Employee Related Liabilities Current
AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent
51919000
CY2020Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
317092000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
115284000
CY2019Q4 gkos Cash Settled Stock Options Liability Fair Value Disclosure
CashSettledStockOptionsLiabilityFairValueDisclosure
6685000
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6685000
CY2019Q2 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
CY2020Q2 gkos Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount
FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount
0
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
gkos Lessee Operating Lease Period For Lease Termination
LesseeOperatingLeasePeriodForLeaseTermination
P1Y
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1527000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3197000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3123000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2230000
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
3543000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2023000
CY2020Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
5184000
CY2020Q2 gkos Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
2052000
CY2020Q2 gkos Finance Lease Liability Payments Due Year Six
FinanceLeaseLiabilityPaymentsDueYearSix
5340000
CY2020Q2 gkos Lessee Operating Lease Liability Payments Due Year Seven
LesseeOperatingLeaseLiabilityPaymentsDueYearSeven
2112000
CY2020Q2 gkos Finance Lease Liability Payments Due Year Seven
FinanceLeaseLiabilityPaymentsDueYearSeven
5500000
CY2020Q2 gkos Lessee Operating Lease Liability Payments Due After Year Seven
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSeven
2112000
CY2020Q2 gkos Finance Lease Liability Payments Due After Year Seven
FinanceLeaseLiabilityPaymentsDueAfterYearSeven
107521000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18376000
CY2020Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
127088000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3041000
CY2020Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
66878000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
15335000
CY2020Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
60210000
CY2020Q2 gkos Lessee Operating Lease Option To Extend Value
LesseeOperatingLeaseOptionToExtendValue
12000000.0
CY2020Q2 gkos Lessee Financing Lease Option To Extend Value
LesseeFinancingLeaseOptionToExtendValue
75800000
us-gaap Lessee Operating Lease Lease Not Yet Commenced Existence Of Option To Extend
LesseeOperatingLeaseLeaseNotYetCommencedExistenceOfOptionToExtend
true
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15051000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
251249000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
266300000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2595000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
263705000
CY2020Q2 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15051000
CY2020Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
436283000
CY2019Q4 gkos Intangible Assets Gross Including Goodwill
IntangibleAssetsGrossIncludingGoodwill
451334000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2595000
CY2019Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
448739000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
12456000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
24912000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
24912000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
24912000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
24619000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
139438000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
251249000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31558000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58600000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86894000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
112626000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31558000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58600000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
86894000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
112626000
gkos Period For Payment On Invoice Terms
PeriodForPaymentOnInvoiceTerms
P30D
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
gkos Share Based Compensation Number Of Plans
ShareBasedCompensationNumberOfPlans
4
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
gkos Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Percentage On First Anniversary Date Of Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPercentageOnFirstAnniversaryDateOfGrant
0.25
gkos Share Based Compensation Arrangement By Share Based Payment Award Award Remaining Vesting Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod
P3Y
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10897000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8247000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24902000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15376000
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
62900000
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.156
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.077
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-7800000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
72000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
18700000
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13600000
CY2020Q1 gkos Coronavirus Aid Relief And Economic Security Act Carryback Net Operating Losses Period
CoronavirusAidReliefAndEconomicSecurityActCarrybackNetOperatingLossesPeriod
P5Y
CY2020Q2 gkos Income Tax Expense Benefit From Coronavirus Aid Relief And Economic Security Act
IncomeTaxExpenseBenefitFromCoronavirusAidReliefAndEconomicSecurityAct
-400000
CY2020Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
8800000
CY2019Q2 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2020Q2 gkos Restricted Cash Pledged For Letter Of Credit
RestrictedCashPledgedForLetterOfCredit
8800000
CY2020Q2 gkos Number Of Months Of Lease Term For Adjustments Of Letters Of Credit Balance Outstanding To Begin
NumberOfMonthsOfLeaseTermForAdjustmentsOfLettersOfCreditBalanceOutstandingToBegin
37
gkos Frequency Of Adjustments Of Letters Of Credit Balance Outstanding
FrequencyOfAdjustmentsOfLettersOfCreditBalanceOutstanding
P12M
gkos Adjustment Percentage Of Letters Of Credit Balance Outstanding
AdjustmentPercentageOfLettersOfCreditBalanceOutstanding
0.20
CY2020Q2 gkos Minimal Amount Of Letters Of Credit Balance Outstanding After Adjustments
MinimalAmountOfLettersOfCreditBalanceOutstandingAfterAdjustments
2000000.0
CY2020Q2 gkos Number Of Other Irrevocable Letters Of Credit Outstanding
NumberOfOtherIrrevocableLettersOfCreditOutstanding
2
CY2020Q2 gkos Restricted Cash Pledged For Office Lease Agreement
RestrictedCashPledgedForOfficeLeaseAgreement
400000
CY2020Q2 gkos Restricted Cash Pledged For Credit Card Program
RestrictedCashPledgedForCreditCardProgram
200000
CY2020Q2 gkos Restructuring Headcount Reduction Number
RestructuringHeadcountReductionNumber
40
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
800000
us-gaap Payments For Restructuring
PaymentsForRestructuring
4100000
CY2020Q2 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
5300000
CY2020Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
4100000
CY2019Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
3700000
CY2020Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
4200000
CY2019Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
3500000
CY2020Q2 gkos Other Commitment Obligation Amount
OtherCommitmentObligationAmount
5400000
CY2019Q4 us-gaap Restructuring Reserve
RestructuringReserve
4096000
us-gaap Restructuring Charges
RestructuringCharges
796000
us-gaap Payments For Restructuring
PaymentsForRestructuring
4085000
CY2020Q2 us-gaap Restructuring Reserve
RestructuringReserve
807000
gkos Number Of Business Activities
NumberOfBusinessActivities
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
0001558370-20-009980-index-headers.html Edgar Link pending
0001558370-20-009980-index.html Edgar Link pending
0001558370-20-009980.txt Edgar Link pending
0001558370-20-009980-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gkos-20200630.xsd Edgar Link pending
gkos-20200630ex103f88cf0.htm Edgar Link pending
gkos-20200630ex103f88cf0001.jpg Edgar Link pending
gkos-20200630ex104f393d1.htm Edgar Link pending
gkos-20200630ex10506328d.htm Edgar Link pending
gkos-20200630ex106463f66.htm Edgar Link pending
gkos-20200630ex3111bd1c7.htm Edgar Link pending
gkos-20200630ex312859a24.htm Edgar Link pending
gkos-20200630ex321496080.htm Edgar Link pending
gkos-20200630ex322ea1ba1.htm Edgar Link pending
gkos-20200630x10q.htm Edgar Link pending
gkos-20200630x10q_htm.xml Edgar Link completed
gkos-20200630_cal.xml Edgar Link unprocessable
gkos-20200630_def.xml Edgar Link unprocessable
gkos-20200630_lab.xml Edgar Link unprocessable
gkos-20200630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending